2015 - 2016 LEGISLATURE
July 31, 2015 - Introduced by Senators Wanggaard, Wirch, L. Taylor, Gudex,
Bewley, C. Larson, Petrowski, Harris Dodd, Marklein, Ringhand and Roth,
cosponsored by Representatives Krug, Kahl, Kitchens, Sargent, Spiros,
Goyke, E. Brooks, Doyle, Macco, Danou, Murphy, Berceau, Subeck, Tittl,
Ohnstad, Craig, Meyers, Weatherston, Pope, Brandtjen, Hebl, Petryk,
Brostoff and C. Taylor. Referred to Committee on Judiciary and Public
SB221,1,2 1An Act to amend 961.14 (4) (t) of the statutes; relating to: definition of
Analysis by the Legislative Reference Bureau
Current law designates tetrahydrocannabinols (THC) as a schedule I
controlled substance. Current law specifies that THC does not include cannabidiol
(CBD oil) in a form without a psychoactive effect that is dispensed by a pharmacy or
physician approved by the Controlled Substances Board or that is possessed by an
individual who has documentation from a physician that the CBD oil is used for the
treatment of a seizure disorder. This bill eliminates the requirement that, to be
excluded from the definition of THC, the CBD oil must be dispensed by an approved
pharmacy or physician or possessed by an individual with such documentation.
The people of the state of Wisconsin, represented in senate and assembly, do
enact as follows:
SB221,1 3Section 1. 961.14 (4) (t) of the statutes is amended to read:
SB221,2,24 961.14 (4) (t) Tetrahydrocannabinols, commonly known as "THC", in any form
5including tetrahydrocannabinols contained in marijuana, obtained from marijuana,
6or chemically synthesized, except that tetrahydrocannabinols do not include

1cannabidiol in a form without a psychoactive effect that is dispensed or documented
2as provided in s. 961.38 (1n)
SB221,2,33 (End)